Clinical Trial Update: Chromium and Insulin Action [Phase 4]

View source ↗

Summary

This Phase 4 trial investigated chromium supplementation and its effect on insulin action in people with type 2 diabetes mellitus and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Chromium (Chromium)

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED